Prescription medications to increase testosterone level, now referred to as testosterone replacement therapy (TRT) have been linked to a significantly increased risk of:
- heart attack
- blood clots
- prostate cancer
- deep vein thrombosis
- sleep apnea.
Researchers found men who used testosterone therapy were 30 percent more likely to have a heart attack, stroke, or die after three years of use. Furthermore, men who started the study with clear, unobstructed coronary arteries were just as likely to have a heart attack, stroke or die as men who entered the study with established coronary artery disease.
Testosterone therapy medications include the following prescription topical treatments:
The FDA approved use for these drugs is to help boost testosterone levels in men who have a deficiency of the male hormone (hypogonadism), a condition which afflicts approximately 3 to 7% of the male population in the US. Symptoms of low testosterone include decreased libido and low energy. Current lawsuits have accused the manufacturers of aggressive marketing tactics to both doctors and the public in an attempt to capture a much larger market share by promoting the use of TRT for off-label uses–a fountain of youth for the over 65 group and as a physical enhancer for younger men.
The product liability attorneys of The Ruth Law Team have determined that there is sufficient evidence of liability on the part of the manufacturers for their failure to adequately warn both consumers and physicians of serious health risks.